Edition:
United Kingdom

People: GW Pharmaceuticals PLC (GWPH.OQ)

GWPH.OQ on NASDAQ Stock Exchange Global Market

164.98USD
21 Sep 2018
Change (% chg)

$-5.12 (-3.01%)
Prev Close
$170.10
Open
$170.01
Day's High
$171.84
Day's Low
$163.18
Volume
243,758
Avg. Vol
104,446
52-wk High
$174.50
52-wk Low
$96.43

Mackey, Catherine 

Dr. Catherine J. Mackey is Non-Executive Independent Director of the Company. Dr. Mackey is an experienced corporate executive, director and advisor with over thirty years of accomplishment in the biotechnology, pharmaceutical, and agricultural industries. She is currently Chief Executive Officer of CYPrus Therapeutics, Inc. and Chairman of the Board of Cour Pharmaceutical Development. In addition, she serves on the Board of Directors of Rady Children's Hospital and as an advisor to several companies. Dr. Mackey previously served as Senior Vice President of Pfizer Worldwide R&D and Director, of Pfizer's La Jolla Laboratories, where she built Pfizer La Jolla into one of Pfizer's main pharmaceutical research and development sites with over 1000 employees and a robust drug pipeline. Prior to that role she served as head of Strategic Alliances and also Genomic and Proteomic Sciences for Pfizer. Dr. Mackey spent the first part of her career in agricultural biotechnology, including as Vice President of DEKALB Genetics, Inc. Dr. Mackey received her B.S. and Ph.D. degrees in microbiology and genetics from Cornell University.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Geoffrey Guy

1,695,890

Justin Gover

1,390,240

James Noble

61,984

Adam George

749,989

Christopher Tovey

460,735

Julian Gangolli

--
As Of  30 Sep 2014